(Nasdaq:MODD) has shared new data highlighting the use of its insulin pump technology to deliver GLP-1 therapeutics.

In previous treat-to-target trials, adjustments to the dose of basal insulin have been made at least weekly, according to ...

Medtronic, Beta Bionics and Tandem Diabetes Care showcased planned patch pumps at the conference, while Senseonics shared ...

VX-880 stem cell therapy led to 92% reduction in insulin use, with 10 out of 12 patients eliminating injections entirely in a ...

CHICAGO -- A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the ...

After years of preparation, Eli Lilly is on the brink of launching a fully connected and personalised diabetes management ... brings together a pre-filled insulin pen, the TempoSmart app and ...

“Inhaled insulin can quickly get to the carbohydrates that are in the bloodstream, get them into the cells and out of the ...

Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both. The chronic hyperglycemia of diabetes is ...

Two years ago, Eli Lilly started working with Dexcom to integrate continuous glucose monitoring (CGM) into its insulin ... insulin pens. “CGMs provide people with diabetes and their healthcare ...

Jennie Brown said the walks "had been really supportive and really helpful" Diabetes super clinics are being expanded across Cornwall to help educate patients and improve long term well-being ...